Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 80

1.

Treatment issues for children with epilepsy transitioning to adult care.

Nabbout R, Camfield CS, Andrade DM, Arzimanoglou A, Chiron C, Cramer JA, French JA, Kossoff E, Mula M, Camfield PR.

Epilepsy Behav. 2017 Feb 7. pii: S1525-5050(16)30631-X. doi: 10.1016/j.yebeh.2016.11.008. [Epub ahead of print] Review.

PMID:
28188045
2.

Phytochemistry of Cannabis sativa L.

ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A.

Prog Chem Org Nat Prod. 2017;103:1-36. doi: 10.1007/978-3-319-45541-9_1.

PMID:
28120229
3.

Is there a role for cannabidiol in psychiatry?

Khoury JM, Neves MC, Roque MA, Queiroz DA, de Freitas AA, de Fátima Â, Moreira F, Garcia FD.

World J Biol Psychiatry. 2017 Jan 23:1-34. doi: 10.1080/15622975.2017.1285049. [Epub ahead of print]

PMID:
28112021
4.

Targeting the Endocannabinoid System in Psychiatric Illness.

Katzman MA, Furtado M, Anand L.

J Clin Psychopharmacol. 2016 Dec;36(6):691-703.

PMID:
27811555
5.

Cannabidiol: a potential treatment for post Ebola syndrome?

Reznik SE, Gardner EL, Ashby CR Jr.

Int J Infect Dis. 2016 Nov;52:74-76. doi: 10.1016/j.ijid.2016.09.020.

6.

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function.

Gruber SA, Sagar KA, Dahlgren MK, Racine MT, Smith RT, Lukas SE.

Front Pharmacol. 2016 Oct 13;7:355.

7.

Endocannabinoid signaling in social functioning: an RDoC perspective.

Karhson DS, Hardan AY, Parker KJ.

Transl Psychiatry. 2016 Sep 27;6(9):e905. doi: 10.1038/tp.2016.169. Review.

8.

Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats.

Mahmud A, Gallant S, Sedki F, D'Cunha T, Shalev U.

J Psychopharmacol. 2017 Jan;31(1):96-104. doi: 10.1177/0269881116667706.

PMID:
27624146
9.

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.

Lawn W, Freeman TP, Pope RA, Joye A, Harvey L, Hindocha C, Mokrysz C, Moss A, Wall MB, Bloomfield MA, Das RK, Morgan CJ, Nutt DJ, Curran HV.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3537-52. doi: 10.1007/s00213-016-4383-x.

10.

Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.

Weinstein A, Livny A, Weizman A.

Curr Pharm Des. 2016;22(42):6366-6379. doi: 10.2174/1381612822666160822151323.

PMID:
27549374
11.

Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects.

Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS.

PLoS One. 2016 Jul 14;11(7):e0158779. doi: 10.1371/journal.pone.0158779. Erratum in: PLoS One. 2016;11(8):e0162087.

12.

Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

Zlebnik NE, Cheer JF.

Annu Rev Neurosci. 2016 Jul 8;39:1-17. doi: 10.1146/annurev-neuro-070815-014038.

PMID:
27023732
13.

Prohedonic Effect of Cannabidiol in a Rat Model of Depression.

Shoval G, Shbiro L, Hershkovitz L, Hazut N, Zalsman G, Mechoulam R, Weller A.

Neuropsychobiology. 2016;73(2):123-9. doi: 10.1159/000443890.

PMID:
27010632
14.
15.

THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.

Fernández Ó.

Eur Neurol. 2016;75 Suppl 1:1-3. doi: 10.1159/000444234. Review.

PMID:
26901342
16.

Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.

Linge R, Jiménez-Sánchez L, Campa L, Pilar-Cuéllar F, Vidal R, Pazos A, Adell A, Díaz Á.

Neuropharmacology. 2016 Apr;103:16-26. doi: 10.1016/j.neuropharm.2015.12.017.

PMID:
26711860
17.

Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans.

Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL.

J Addict Med. 2015 May-Jun;9(3):204-10. doi: 10.1097/ADM.0000000000000118.

18.

Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.

Centonze D.

Eur Neurol. 2014;72 Suppl 1:6-8. doi: 10.1159/000367615.

PMID:
25278116
19.

Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.

Laprairie RB, Bagher AM, Kelly ME, Dupré DJ, Denovan-Wright EM.

J Biol Chem. 2014 Sep 5;289(36):24845-62. doi: 10.1074/jbc.M114.557025.

20.

Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa.

de Mello Schier AR, de Oliveira Ribeiro NP, Coutinho DS, Machado S, Arias-Carrión O, Crippa JA, Zuardi AW, Nardi AE, Silva AC.

CNS Neurol Disord Drug Targets. 2014;13(6):953-60. Review.

PMID:
24923339
Items per page

Supplemental Content

Loading ...
Support Center